// App-Quantinova.ai

11019 2014 AHA : Incidence and Predictors for Late Acquired Stent Malapposition of Drug-Eluting-Stents With Second-Generation Permanent and Biodegradable Polymer-Coatings - A Prospective, Randomized Comparison Using Optical Coherence Tomography

Researchers

Presenter

  • Clemens Gangl

Principal Investigators

  • Daniel Dalos

  • Sabine Scherzer

  • Lisa Krenn

  • Gerhard Kreiner

  • Georg Delle-Karth

  • Thomas Neunteufl

  • Rudolf Berger

Medical Centers

  • Medical University of Vienna, Vienna, Austria

Locations

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved